What Purdue Pharma’s settlement with Oklahoma means for the opioid crisis
Here's a breakdown of how significant the $270 million settlement is in the context of the nation's continued struggle with opioids, overdoses and need for harm reduction and treatment.
Will fewer opioid prescriptions help kick the crisis?
Of all physicians, primary care doctors most frequently doled out first-time opioid prescriptions, suggested a study published this week in the New England Journal of Medicine.
Watch 9:36
This grieving family wants pharmaceutical companies held accountable for opioid deaths
An estimated 400,000 Americans have died as a result of opioid use. But grieving families say the national response to the health crisis is inadequate. In her coverage of the epidemic, Associated Press reporter Claire Galofaro profiled Cheryl Juaire, who…
Drug maker pushed OxyContin despite danger signs, prosecutor says
Details were made public in a case brought by Massachusetts Attorney General Maura Healey that accuses Purdue Pharma, its executives and members of the Sackler family of deceiving patients and doctors about the risks of opioids and pushing prescribers to…
Bloomberg Philanthropies said over the next three years it will help up to 10 states address the causes of opioid addiction and strengthen prevention and treatment programs.
Another drop in U.S. life expectancy is being called a ‘wakeup call’. What’s happening?…
On Wednesday, President Donald Trump signed a bill that will expand access to certain kinds of opioid treatment. Keith Humphreys, former drug policy advisor during the Obama and Bush administrations, and Gary Mendell, the CEO of an addiction recovery nonprofit,…
Trump is expected to speak at 2 p.m. EDT today. Watch his remarks here.
The research team behind a new letter published in the Annals of Internal Medicine did not make a conclusion that these prescriptions were inappropriate.
